$CERO Cashflow Statement | Understand Stock

$CERO

$0.10 +$0.00 (0.0%) Close

$CERO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flow

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 11 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 7 months to Dec 31, 2021
Net loss
Successor
Predecessor
Total net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Unrealized loss on marketable securities held in Trust Account
Interest income earned on marketable securities held in Trust Account
Income tax benefit
Gain from settlement of liabilities with vendors
Depreciation expense
Stock-based compensation
Amortization of right-to-use operating lease asset
Inducement expense
Successor
Series C
Non-cash interest expense
Foreign currency transaction gain included in other income (expenses)
Write off of deferred offering costs
Gain on revaluation of earnout and derivative liabilities

Change in assets and liabilities:
Prepaid expenses and other current assets
Successor
Predecessor
Total prepaid expenses and other current assets
Due to Affiliates
Income tax payable
Accounts payable and accrued expenses
Franchise tax payable
Accounts payable
Accrued liabilities
Insurance payable
Operating lease liability
Net cash used in operating activities
Successor
Predecessor
Total net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash deposited to Trust Account
Cash withdrawn from Trust Account for taxes
Cash withdrawn from Trust Account in connection with redemption
Investment of restricted cash into marketable securities in the Trust Account
Proceeds from sale of equity securities
Net cash provided by investing activities
Successor
Total net cash provided by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from initial public offering
Proceeds from promissory note - related party
Redemption of Class A common stock
Proceeds from issuance of convertible notes
Issuance costs for convertible notes
Common stock subscription deposit
Cash proceeds from exercise of common stock options
Advances from shareholder
Payment of sponsor loans
Successor
Total payment of sponsor loans
Proceeds from exercise of Series A Preferred warrants
Proceeds from short term borrowings, net
Payments for short term borrowings
Proceeds from share purchases under ELOC, net of issuance costs
Successor
Total proceeds from share purchases under ELOC, net of issuance costs
Proceeds received from sale of Series B Preferred Stock, net of issuance costs
Proceeds received from sale of Series C Preferred Stock, net of issuance costs
Proceeds received from sale of Series D Preferred Stock, net of issuance costs
Proceeds received from sale of Series E Preferred Stock, net of issuance costs
Proceeds received from sale of common stock and warrants, net of issuance costs
Successor
Total proceeds received from sale of common stock and warrants, net of issuance costs

Proceeds received from sale of pre-funded warrants, net of issuance costs
Successor
Total proceeds received from sale of pre-funded warrants, net of issuance costs

Proceeds from exercise of pre-funded warrants
Cash redemption of Series C Preferred Stock
Payment of offering costs
Successor
Total payment of offering costs

Net cash provided by financing activities
Successor
Predecessor
Total net cash provided by financing activities

NET CHANGE IN CASH
Cash and cash equivalents
Successor
Predecessor
Total cash and cash equivalents
NET CHANGE IN CASH AND RESTRICTED CASH
Net increase (decrease) in cash and cash equivalents
Cash, restricted cash and cash equivalents at beginning of period
Successor
Predecessor
Total cash, restricted cash and cash equivalents at beginning of period
Cash, restricted cash and cash equivalents at end of period
Successor
Predecessor
Total cash, restricted cash and cash equivalents at end of period
Deferred underwriting commissions payable charged to additional paid in capital
Accretion for Class A common stock to redemption value
NON-CASH FINANCING ACTIVITIES:
Issuance of common shares to Keystone Capital LLC for equity line of credit
Issuance of common shares to Arena Capital Partners for equity line of credit
Stock subscription receivables
Conversion of Series A, Series B, Series C and Series D preferred stock to common stock
Stock subscriptions receivable
Increase in deferred offering costs and accounts payable
Deemed dividend – common stock liability, 13,835 shares
Exercise of warrants for Series A Preferred Stock through extinguishment of accrued expenses
Deemed dividend – common stock liability, 692 shares
Successor
Series A
Series B
Reclassification of deferred offering costs to additional paid-in capital
Reclassification of accrued expenses to accounts payable
Issuance of Series D preferred stock for investment in equity securities
Write off of subscription receivable deemed offering cost
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
Accretion of Class A common stock subject to possible redemption
Shareholder redemption liability
Conversion of Class B common to Class A common
Excise tax liability accrued for Class A common stock redemptions
Cash, restricted cash and cash equivalents
Successor
Predecessor
Total cash, restricted cash and cash equivalents
Cash and cash equivalents
Successor
Total cash and cash equivalents
Restricted cash
Successor
Total restricted cash

Comments